Article
Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects.
Immunogenetics - 1 Dec 2010
Molderings Gerhard J, Meis Kirsten, Kolck Ulrich W, Homann Jürgen, Frieling Thomas
Abstract excerpt
Systemic mast cell activation syndrome is a mast cell disorder characterized by an unregulated increased activation of mast cells leading to a pathologically enhanced release of mediators. Mutations in tyrosine kinase kit which crucially determines mast cell activity have been suggested as a necessary condition for the development of a clinically symptomatic mast cell disease. At the level of mRNA in mast cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
